Slides
Page 1
Fourth quarter results 12 February 2026
Page 2
Disclaimer This presentation has been prepared by Orkla ASA (the “Company”) solely for information purposes. The presentation does not c onstitute an invitation or offer to acquire, purchase or subscribe for securities. Certain statements included in this presentation contain various forward -looking statements that reflect management’s current vi ews with respect to future events and financial and operational performance. The words “believe,” “expect,” “anticipate,” “intend,” “may,” “pl an,” “estimate,” “should,” “could,” “aim,” “target,” “might,” or, in each case, their negative, or similar expressions identify certain of the se forward-looking statements. Others can be identified from the context in which the statements are made. Although we believe that the expectat ions reflected in such forward-looking statements are reasonable, these forward -looking statements are based on a number of assumptions and foreca sts that, by their nature, involve risk and uncertainty. Various factors could cause our actual results to differ materially from those pr ojected in a forward- looking statement or affect the extent to which a particular projection is realized. Factors that could cause these differenc es include but are not limited to the Company’s ability to operate profitably, maintain its competitive position, to promote and improve its reputat ion and the awareness of the brands in its portfolio, to successfully operate its growth strategy and the impact of changes in pricing policies, po litical and regulatory developments in the markets in which the Company operates, and other risks. The information and opinions contained in this document are provided as at the date of this presentation and are subject to c hange without notice. No representation or warranty (expressed or implied) is made as to, and no reliance should be placed on, the fairness, accura cy or completeness of the information contained herein. Accordingly, neither the Company nor its subsidiary undertakings or any of such person’s officers or employees accepts any liability whatsoever arising directly or indirectly from the use of this document. 2All Alternative Performance Measures (APMs) are presented in the appendices. All figures in NOK million unless otherwise stated
Page 3
Q4 2025 16.7% EBIT (adj.) growth2 NOK 1.74 EPS (adj.)3 4.5% Organic growth1 3 Note: 1. Organic growth in the Consolidated Portfolio Companies; 2. Underlying EBIT (adj.) growth in the Consolidated Portfolio Companies including Orkla ASA and Business Services; 3. Fully diluted
Page 4
Organic growth Note: 1. Growth year-over-year. Figures not adjusted for timing effects such as the timing of Easter, etc. 4 Organic growth1 | Consolidated Portfolio Companies 5.9% 1.0% 2.3% 2.6% 1.5% 2.3% 1.4% 1.3% 1.8% -0.6% 2.6% 1.0% 1.2% 1.8% -1.1% 2.4% 3.1% 2.8% Q4’23 Q1’24 Q2’24 Q3’24 Q4’24 Q1’25 Q2’25 Q3’25 Q4’25 5.3% 3.6% 3.3% 3.9% 3.3% 1.2% 3.8% 4.4% 4.5% Volume/mix Price
Page 5
EBIT (adj.) by portfolio company Note: 1. Orkla’s share (42.7%) of Jotun EBIT; 2. Including Business Services 5 718 2,004 1,920 493 67 353 145 102 97 18 11 Orkla Foods Orkla Snacks Orkla Home & Personal Care Orkla Food Ingredients Orkla Health Orkla India The European Pizza Company Orkla House Care Health and Sports Nutrition Group Consolidated Portfolio Companies Orkla ASA2 Consolidated Portfolio Companies incl. Orkla ASA2 (84) Underlying EBIT (adj.) growth (Q4-25 vs. Q4-24) Anchor Grow and build Transform or exit 3.2% 16% 4.2% 14% 15% 37% 113% 19%70% 631 Jotun1 15% 17% EBIT (adj.) in NOKm 28%
Page 6
EBIT (adj.) margin Note: 1. Including Orkla ASA and Business Services Abbreviation: R12M = Rolling twelve-month (also applicable to other pages in this presentation) 6 11.3% 11.7% 9.0% 10.1% 10.6% 8.0% 8.5% 9.0% 9.5% 10.0% 10.5% 11.0% 11.5% 12.0% Q4’19 Q1’20 Q2’20 Q3’20 Q4’20 Q1’21 Q2’21 Q3’21 11.0% Q4’21 Q1’22 Q2’22 Q3’22 9.1% Q4’22 Q1’23 Q2’23 Q3’23 Q4’23 Q1’24 Q2’24 Q3’24 Q4’24 Q1’25 Q2’25 Q3’25 Q4’25 Consolidated Portfolio Companies | R12M EBIT (adj.) margin1
Page 7
7 6.9% 11.8% 2023 CAGR2 CAGR (2023-26)3 8-10% 9.0% 10.6% 2023 R12M 20263 10.5-11% 9.9% 12.4% 2023 R12M 20263 13% Portfolio company targets 2023-2026 (consolidated)1 Note: 1. Including Orkla ASA and Business Services; 2. CAGR from 31/12/2023 to 31/12/2025; 3. Total of the targets for the C onsolidated Portfolio Companies communicated at the Capital Markets Day in November 2023 Return on Capital Employed (ROCE) EBIT (adj.) margin Underlying EBIT (adj.) growth 7
Page 8
Financial performance Arve Regland, EVP and CFO
Page 9
Income statement Note: 1. Earnings per share (diluted) 9 Key quarterly figures Q4’25 Q4’24 Operating revenues 18,775 18,395 EBIT (adj.) 1,977 1,771 Other income and expenses (151) (180) EBIT 1,826 1,591 Profit from Jotun & other associates 505 371 Net interest and other financial items (191) (239) Taxes (350) (384) Discontinued operations 301 112 Profit attributable to non-controlling interests (203) (91) Profit attributable to owners of the parent 1,888 1,360 Earnings per share (adj.)1 1.74 1.40 Earnings per share1 1.89 1.36
Page 10
Cash flow 10 Cash flow statement (NOKbn) 2025 2024 EBIT (adj.) 7.6 7.1 Depreciation and write-downs 2.7 2.7 Change in net working capital 0.3 0.7 Net replacement investments (2.7) (2.0) Cash flow from other income & exp. and pensions (0.2) (0.3) Cash flow from operations 7.8 8.1 Tax paid (1.4) (1.0) Dividend received (from Jotun) 1.4 1.0 Cash flow from financial items and other transactions (0.8) (1.1) Cash flow before capital allocation 6.9 7.0
Page 11
Capital allocation and leverage . 11 NIBD 31.12.2024 6.9 Cash flow before capital allocation 11.2 Dividends paid and sale/purchase of treasury shares 0.7 Expansion investments 0.6 Purchase of companies 7.5 Sale of companies/discont’d operations 0.1 Currency effects NIBD 31.12.2025 16.0 14.2 1.4x EBITDA 0.9x EBITDA Figures in NOK billion (excl. Orkla Food Ingredients)
Page 12
Portfolio companies All Alternative Performance Measures (APMs) are presented in the appendices. All figures in NOK million unless otherwise stated.
Page 13
1,298 1,890 1,815 1,900 1,477 15.0% 22.0% 21.0% 22.0% 17.4% Q4’24 Q1’25 Q2’25 Q3’25 Q4’25 • Underlying revenue growth of 8.4%, and growth across all segments and regions • Underlying operating profit growth of 28% driven by volume growth and improved gross margins • Jotun expects sales growth to outpace market growth in 2026, but continued negative FX translation effects is expected to impact reported results Jotun Anchor Grow and build Transform or exit 14.6% 6.4% -0.6% -2.0% -1.9% Q4’24 Q1’25 Q2’25 Q3’25 Q4’25 REVENUE GROWTH YoY OPERATING PROFIT / EBIT EBIT EBIT margin (42.7% - associated company) Note: All figures refer to the Jotun Group Revenue (NOKm) 8,501 Revenue growth YoY (Fixed rate) 8.4% ROCE (R12M) 33.9% KEY FIGURES | Q4 2025 13 28% Underlying growth
Page 14
• Organic growth driven by Sweden and the Czech Republic. Weaker development in Norway • Organic growth was higher in prioritized growth platforms • EBIT (adj.) growth driven by reduced SG&A, partly from periodisation effects Orkla Foods Anchor Grow and build Transform or exit 0.9% 0.2% Q4’24 0.9% -3.8% Q1’25 Q2’25 1.6% -0.8% Q3’25 0.2%0.2% Q4’25 1.1% -2.9% 1.0% 0.8% 0.4% Price Volume/mix ORGANIC GROWTH 681 589 614 700 718 12.3% Q4’24 12.5% Q1’25 12.4% Q2’25 12.5% Q3’25 12.6% Q4’25 EBIT (ADJ.) EBIT (adj.) EBIT (adj.) margin (R12M) KEY FIGURES | Q4 2025 3.2% Underlying growth 14 Revenue (NOKm) 5,633 ROCE (R12M) 14.9% Cash conversion (R12M) 95%
Page 15
• Positive volume/mix growth driven by snacks category and BUBS • EBIT (adj.) growth from all categories, led by snacks category Orkla Snacks 6.8% -0.5% Q4’24 6.0% -4.1% Q1’25 6.1% -1.8% Q2’25 9.1% -1.6% Q3’25 6.2% 1.8% 4.3% 7.5% Q4’25 7.0% 1.7% 5.3% ORGANIC GROWTH 424 260 263 313 493 0 500 0.01 13.1% Q4’24 13.0% Q1’25 12.8% Q2’25 12.3% Q3’25 Q4’25 12.7% EBIT (adj.) EBIT (adj.) margin (R12M) Revenue (NOKm) 3,051 ROCE (R12M) 12.1% Cash conversion (R12M) 113% KEY FIGURES | Q4 2025 EBIT (ADJ.) Anchor Grow and build Transform or exit 15.5% Underlying growth 15 Price Volume/mix
Page 16
62 87 89 108 67 0 0.01 0.02 11.7% Q4’24 11.9% Q1’25 12.0% Q2’25 12.3% Q3’25 12.4% Q4’25 • Revenue decline due to destocking for a customer in Norway • Increased market shares in all markets • EBIT (adj.) growth due to cost savings and phasing Orkla Home & Personal Care 0.5% 9.0% Q4’24 0.7% 6.1% Q1’25 0.5% 7.9% Q2’25 -0.4% 1.3% Q3’25 -0.8%-2.0% Q4’25 9.5% 6.8% 8.5% 0.9% -2.8% Price Volume/mix ORGANIC GROWTH EBIT (ADJ.) EBIT (adj.) EBIT (adj.) margin (R12M) Revenue (NOKm) 704 ROCE (R12M) 24.5% Cash conversion (R12M) 112% KEY FIGURES | Q4 2025 4.2% Underlying growth Anchor Grow and build Transform or exit 16
Page 17
• Broad-based organic revenue growth from both volume/mix and price increase • EBIT (adj.) growth in all clusters • Divestment of Icelandic companies Orkla Food Ingredients Anchor Grow and build Transform or exit 0.5% 3.4% Q4’24 3.6% 1.0% Q1’25 3.8% 5.4% Q2’25 4.4% 3.9% Q3’25 4.0% 4.6% 9.2% 8.3% Q4’25 8.3% 3.8% 4.4% Price Volume/mix ORGANIC GROWTH 314 280 460 413 353 0 200 400 600 6.8% Q4’24 6.9% Q1’25 7.1% Q2’25 7.0% Q3’25 Q4’25 7.1% EBIT (ADJ.) EBIT (adj.) EBIT (adj.) margin (R12M) Revenue (NOKm) 5,453 ROCE (R12M) 12.4% Cash conversion (R12M) 88% KEY FIGURES | Q4 2025 (Orkla ownership 59.4%) 13.6% Underlying growth 17
Page 18
85 310 209 248 145 0 500 12.8% Q4’24 12.7% Q1’25 11.9% Q2’25 11.3% Q3’25 11.9% Q4’25 • Organic growth driven by food supplements and wound care categories • Underlying EBIT (adj.) growth driven by comparison to abnormally weak quarter last year Orkla Health 3.6% 2.5% Q4’24 3.4% -0.9% Q1’25 3.1% -0.9% Q2’25 0.9% 1.6% Q3’25 3.6% 1.6% Q4’25 6.2% 2.5% 2.2% 2.5% 5.2% Price Volume/mix ORGANIC GROWTH EBIT (ADJ.) EBIT (adj.) EBIT (adj.) margin (R12M) Revenue (NOKm) 1,830 ROCE (R12M) 9.2% Cash conversion (R12M) 111% KEY FIGURES | Q4 2025 70.0% Underlying growth Including NutraQ 18 Anchor Grow and build Transform or exit
Page 19
• Organic growth driven by volume growth • Price development was negative due to declining raw material costs • Underlying EBIT (adj.) growth driven by volume growth, operating efficiencies and cost discipline Orkla India Q4’24 Q1’25 Q2’25 Q3’25 -3.6% -0.1% -1.4% 4.3% Q4’25 8.1% ORGANIC GROWTH EBIT (ADJ.) Revenue (NOKm) 724 EBIT (adj.) margin (Q4’25) 14.1% KEY FIGURES | Q4 2025 The information set out herein does not represent the audited financial information of Orkla India, as per the Indian Accounting Standards (Orkla ownership 75%) 14.7% Underlying growth1 EBIT (adj.) EBIT (adj.) margin (R12M) 19 102 131 131 122 102 0 200 0.00 0.01 0.02 0.03 14.9% Q4’24 16.1% Q1’25 16.3% Q2’25 16.1% Q3’25 Q4’25 16.3% Anchor Grow and build Transform or exit
Page 20
70 77 100 108 97 0 0.0111.1% Q4’24 11.1% Q1’25 11.4% Q2’25 11.5% Q3’25 Q4’25 12.1% Q4’24 Q1’25 Q2’25 Q3’25 0.2% -1.6% 1.2% 2.2% Q4’25 8.1% ORGANIC GROWTH EBIT (ADJ.) EBIT (adj.) EBIT (adj.) margin (R12M) Revenue (NOKm) 834 ROCE (R12M) 8.6% KEY FIGURES | Q4 2025 • Same-store sales growth across all businesses led to a 9.7% increase in consumer sales • Underlying EBIT (adj.) growth of 37%, supported by consumer sales momentum, cost control and prior year receivables write-off The European Pizza Company Cash conversion (R12M) 108% 37.0% Underlying growth 20 Anchor Grow and build Transform or exit
Page 21
21 • Organic revenue of -4.4% driven by order intake changes in UK and continued impact of listings reductions in Benelux • EBIT (adj.) of NOK 18m, representing an underlying growth of 113% due to improved contribution ratio and cost efficiency Orkla House Care • Organic growth of 1.4% driven by the D2C business, but partly offset by lower B2B sales • EBIT (adj.) of NOK 11m, representing an underlying growth of 18.9% driven by improved contribution margin, warehouse efficiency and fixed cost control • Cash conversion of 158%, well above target of >100% Health and Sports Nutrition Group Anchor Grow and build Transform or exit
Page 22
Closing remarks Nils K. Selte, President and CEO
Page 23
µ 23 µµ 2025 HIGHLIGHTS The Board of Directors intends to propose a total dividend of NOK 6 per share (NOK 4 ordinary plus NOK 2 in additional dividend) Solid performance from the Consolidated Portfolio Companies: • Organic growth of 3.5%, including volume/mix growth of 0.9% • Underlying EBIT (adj.) growth of 7%1 • Cash conversion of 101% Structural initiatives: • IPO of Orkla India • Sale of Hydro Power portfolio and Pierre Robert Group Note: 1. Including Orkla ASA and Business Services
Page 24
24 3 COMMITMENTS Perform value-adding structural transactions Reduce the complexity of existing portfolio Drive organic value in existing portfolio
Page 25
25 Capital Markets Day 1 December 2026
Page 26
Q&A
Page 27
Upcoming events 27 Annual General Meeting 23 April 2026 First quarter results 20 May 2026
Page 28
Appendices
Page 29
Net interest-bearing liabilities Note: 1. Including Orkla Food Ingredients NIBD / R12M EBITDA1Net interest-bearing liabilities (NOKbn)1 4.9 2019 4.9 2020 10.8 2021 15.2 2022 16.5 2023 13.7 2024 11.9 2025 6.6 6.4 12.8 17.2 18.8 16.0 14.2 NIBD (ex. leasing) Leasing debt 1.0x 0.9x 1.5x 1.8x 2.0x 1.5x 1.4x 2019 2020 2021 2022 2023 2024 2025 29
Page 30
Funding sources and maturity profile per Q4-25 Funding sources (in NOKbn) Debt maturity average maturity 2.9 years 0 10 2 4 6 8 12 NOKbn 2026 2027 2028 2029 2030 2031 Drawn amounts - Orkla Group excl. Orkla Food Ingredients (ex. leasing) Drawn amounts - Orkla Food Ingredients (ex. leasing) Unutilised credit facilities 2.6 7.0 7.5 5.8 Cash, cash equivalents and interest-bearing assets Bonds and CP Bank Unutilised credit facilities 30
Page 31
Overview of financial targets (1/3) 31 6.6% 0.8% 2023 CAGR Target1,2 2-3% Revenue Anchor -2.2% 0.4% 2023 CAGR Target >2.0% EBIT margin Cash conversion 11.1% 12.6% 2023 R12M Target 13-14% 127% 95% 2023 R12M Target >100% 11.4% 12.7% 2023 R12M Target >15.0% 50% 113% 100% 2023 R12M Target 9.9% 12.1% 13.0% 2023 R12M Target Note: 1. Organic CAGR from 2024 to 2026; 2. Communicated target of positive volume/mix growth CAGR represent period from 31/12/2023 to 31/12/2025; R12M represents rolling twelve months as at end of quarter The target period stretches from 2024 to 2026. Please note that financial targets for each portfolio company were communicated at the Capital Markets Day on 29 November 2023 All revenue measures are organic All EBIT measures are defined as EBIT (adj.) All cash conversion measures are defined as cash flow from operations / EBIT (adj.) ROCE 12.4% 14.9% 2023 R12M Target >15.0% Orkla Foods Orkla Snacks Orkla Home & Personal Care Underlying EBIT Cash conversion 35.5% 24.2% 2023 CAGR Target1 >10.0% 128% 112% 100% 2023 R12M Target Volume-mix EBIT margin Cash conversion ROCE
Page 32
Overview of financial targets (2/3) 32 Grow and build 6.3% 5.7% 2023 CAGR Target1 7-9% 2.6% 1.9% 2023 CAGR Target >5.0% 13.4% 11.9% 14.0% 2023 R12M Target €23m €33m 2023 R12M Target €35-40m Note: 1. Organic CAGR from 2024 to 2026; 2. Orkla Food Ingredients has a target of 5% revenue growth (organic growth of 3-4% (50/50 price and volume/mix)), plus minor add-ons (represents ~1-2% of revenue growth). Underlying EBIT (adj.) target of 9-10%, plus 2-3% additional growth from minor add-ons CAGR represent period from 31/12/2023 to 31/12/2025; R12M represents rolling twelve months as at end of quarter The target period stretches from 2024 to 2026. Please note that financial targets for each portfolio company were communicated at the Capital Markets Day on 29 November 2023 All EBIT measures are defined as EBIT (adj.). EBIT CAGR is related to underlying EBIT (adj.) All cash conversion measures are defined as cash flow from operations / EBIT (adj.) Orkla Food Ingredients Orkla Health The European Pizza Company Revenue Underlying EBIT ROCE Consumer sales Revenue EBIT margin EBIT by 2026 (YE) 8.7% 4.2% 2023 CAGR Target1,2 3-4% 6.9% 10.3% 2023 CAGR Target 9-10% 10.8% 12.4% 2023 R12M Target 12.5-13%
Page 33
Overview of financial targets (3/3) 33 Transform or exit Orkla House Care Health and Sports Nutrition Group Note: 1. Organic CAGR from 2024 to 2026; 2. Communicated target of positive volume/mix growth CAGR represent period from 31/12/2023 to 31/12/2025; R12M represents rolling twelve months as at end of quarter The target period stretches from 2024 to 2026. Please note that financial targets for each portfolio company were communicated at the Capital Markets Day on 29 November 2023 All revenue measures are organic All EBIT measures are defined as EBIT (adj.) All cash conversion measures are defined as cash flow from operations / EBIT (adj.) 9.6% 13.0% 2023 R12M Target 14-15% 10.4% 1.1% 2023 CAGR Target1 >5.0% 2.9% 4.2% 5.0% 2023 R12M Target 158% 100% 2023 R12M Target Neg. Revenue EBIT margin Cash conversion EBIT margin
Page 34
Alternative Performance Measures (APM) Contribution ratio Contribution margin ratio is calculated by dividing the contribution margin by operating revenues. Operating revenues minus variable operating expenses constitute the contribution margin. Variable operating expenses are reported on the financial statement line “operating expenses” and consist of expenses directly related to sales volume. Variable expenses include costs related to input factors such as raw materials and packaging, and variable production costs such as electricity related to production and variable pay. They also include ingoing and outgoing freight costs directly related to sales volume. Costs related to finished goods purchased for resale are included as part of variable operating expenses. Production costs that are relatively constant over time and do not vary according to production volume are not included in the computation of contribution margin; such costs include warehouse costs, payroll expenses linked to factory administration and management staff, and depreciation of production equipment. Contribution margin is a key internal financial figure that illustrates how profitable each portfolio company’s product mix is, and hence also the company’s ability to cover fixed expenses. Contribution margin is an important financial figure with regard to product innovation and product portfolio optimisation. A reconciliation of the Orkla group’s contribution margin is presented in the table above. Organic growth Organic growth shows like-for-like turnover growth for the group’s business portfolio and is defined as the group’s reported change in operating revenues adjusted for effects of the purchase and sale of companies, the re-conclusion and loss of distribution agreements of a material nature, and currency effects. Intra-group transfers of companies and changes in distribution agreements between portfolio companies are also taken into account. In calculating organic growth, acquired companies are excluded 12 months after the transaction date. Sold companies are excluded pro forma 12 months prior to the transaction date. Currency effects are neutralised by translating this year’s turnover at last year’s exchange rates. Organic growth is included in segment information, and is used to identify and analyse the turnover growth of the consolidated portfolio companies. Organic growth provides an important picture of the portfolio companies’ ability to carry out innovation, product development, correct pricing and brand-building. Segment information for each consolidated portfolio company shows how large a part of organic growth is related to price effects and how large a part is linked to volume/mix effects. Price effects are defined as net changes in prices to customers, i.e. changes in customer prices adjusted for factors such as discounts, campaigns and price reductions. The price effects are calculated based on the assumption of unchanged volume. Volume/mix effects are calculated as a residual, and comprise organic growth minus price effects. Volume/mix effects consist of changes in sales volume and/or changes in the product mix sold. EBIT (adj.) EBIT (adj.) shows the group’s current operating profit before items that require special explanation, and is defined as reported operating profit or loss before “Other income and expenses” (OIE). These include M&A costs, restructuring or integration expenses, any major gains on and write-downs of both tangible and intangible assets, and other items that only to a limited degree are reliable measures of the group’s current profitability. EBIT (adj.) margin and growth are derived figures calculated in relation to operating revenues. EBIT (adj.) is one of the group’s most important financial figures, internally and externally. The figure is used to identify and analyse the group’s profitability linked to normal operations and operating activities. Adjustment for items in OIE which to a limited degree are reliable measures of the group’s current operating profit or loss increases the comparability of profitability over time. 34
Page 35
Alternative Performance Measures (APM) Change in underlying EBIT (adj.) Change in underlying EBIT (adj.) shows like-for-like EBIT (adj.) growth for the group’s business portfolio, and is defined as the group’s reported change in EBIT (adj.), adjusted for effects of the purchase and sale of companies, the re-conclusion and loss of distribution agreements of a material nature, and currency effects. Account is also taken of intra-group transfers of companies and changes in distribution agreements between portfolio companies. In calculating the change in underlying EBIT (adj.), acquired companies are included pro forma 12 months prior to the transaction date. Sold companies are excluded pro forma 12 months prior to the transaction date. Currency effects are neutralised by translating this year’s EBIT (adj.) at last year’s currency exchange rates. Where underlying profit performance is mentioned in the report, reference is made to underlying EBIT (adj.) performance. Underlying EBIT (adj.) margin and change therein are derived figures calculated in relation to operating revenues. Underlying EBIT (adj.) growth is used for internal management purposes, including for identifying and analysing underlying profitability growth in the existing business portfolio, and provides a picture of the portfolio companies’ ability to improve profitability in their existing operations. The measure is important because it provides a comparable structure for monitoring the change in profitability over time. Return on Capital Employed (ROCE) ROCE is calculated by dividing a 12-month rolling EBITA (adj.) by the average capital employed in the consolidated portfolio companies. EBITA (adj.) consists of EBIT (adj.) plus depreciation and write-downs of intangible assets. 12-month rolling EBITA (adj.) is used in the calculation. Since depreciation and write-downs of intangible assets are not included in EBITA (adj.), they are also excluded from the capital base. Thus the historical cost ofintangible assets is used in capital employed (see next paragraph). Capital employed represents the working capital of the consolidated portfolio companies and consists of: • Net working capital - consists of the statement of financial position items “Trade receivables”, “Trade payables” and “Inventories”. It also includes payable public charges and some minor receivables and payables related to operations included in “Other receivables and financial assets” and “Other current liabilities”. • Fixed assets • Intangible assets at historical cost - consist of the statement of financial position line “Intangible assets” plus accumulated depreciation and write-downs • Net pension liabilities -Pension assets are included in the statement of financial position line “Associates, joint ventures and other financial assets”, while pension liabilities are included in “Provisions and other non-current liabilities” • Deferred tax on excess value - This item is included in deferred tax which is part of the statement of financial position line “Provisions and other non-current liabilities” 35
Page 36
Alternative Performance Measures (APM) Return on Capital Employed (ROCE) cont. Average capital employed is always an average of the closing balances in the five last reported quarters. ROCE shows the return that the Orkla group receives on the capital invested in the various consolidated portfolio companies. This is an important measurement parameter for assessing whether the portfolio companies’ return exceeds the group’s weighted average cost of capital (WACC), and for comparing the return on the current portfolio with other alternative returns. Earnings per share (adj.) Earnings per share (adj.) show earnings per share adjusted for discontinued operations and “Other income and expenses” after tax and non-controlling interests. Adjustments are also made for any reported gains or losses on sales/purchases of associates and joint ventures, as well as for any reported major profit or loss effects linked to abnormal tax conditions. Net replacement and expansion investments When making investment decisions, the group distinguishes between replacement and expansion investments. Expansion investments are the proportion of overall reported investments deemed to be investments in either new geographical markets or new categories, or investments which represent significant increases in capacity. Net replacement investments include new leases and are reduced by the value of sold fixed assets valued at sale value. The purpose of this distinction is to show how large a part of the investments (replacement) mainly concerns maintenance of existing operations and how large a part of the investments (expansion) are expected to generate increased contributions to profit in future, over and above profit expectations linked to normal operations. Cash conversion Cash conversion is calculated as cash flow from operations as a percentage of EBIT (adj.). Cash flow from operations is defined and presented in the Orkla-format cash flow statement. Cash conversion is an important key figure for Orkla, as it shows how much of EBIT (adj.) has been converted into net interest-bearing liabilities, and thus the financial means available to the group. Net interest-bearing liabilities are the group’s most important management parameter for financing and capital allocation. 36
Page 37
Alternative Performance Measures (APM) Net interest-bearing liabilities Net interest-bearing liabilities are the sum of the group’s interest-bearing liabilities and interest-bearing receivables. Interest-bearing liabilities include bonded loans, bank loans, other loans, lease liabilities and interest-bearing derivatives. Interest-bearing receivables include cash and cash equivalents, interest-bearing derivatives and other interest-bearing receivables. Net interest-bearing liabilities are the group’s primary management parameter for financing and capital allocation, and are actively employed as part of the group’s financial risk management strategy. The Orkla format cash flow statement therefore shows the change in net interest-bearing liabilities at group level. Structure (acquisitions and disposals) Structural growth includes adjustments for the acquisitions of the businesses Freunde der Erfrischung, SnackFood, Kartonage, Eurohansa Toruń, Le Vesuve and Decorgel. Adjustments have also been made for the divestments of Lilleborg, Pierre Robert Group, Fruta Podivín, Kjarnavörur, Gædabakstur and the brand Blomberg’s Gløgg. In 2024, adjustments were made for the acquisitions of the businesses Bubs Godis, Khell-Food and Norstamp. Adjustments were also made for the loss of the distribution agreements for Tropicana and Alpro in Orkla Foods. As part of the transition to a new operating model, the split-up of the former Orkla Care business area entailed the transfer of the dental health business and adjustments for changes in distribution and production agreements between portfolio companies. 37